A Juno and Celgene collaboration will focus on T cell therapeutics for cancer, one in eight people is pre-diabetic but a new study shows a willingness to change behavior if made aware of their risk.
Stephanie Baum | 11:13 am, June 30
Neil Versel | 7:33 pm, June 30
Meghana Keshavan | 7:03 pm, June 30
Chris Seper | 9:22 am, June 26